Quorum Information Technologies is a buy, says Beacon Securities

Auto dealership software company Quorum Information Technologies (Quorum Information Technologies Stock Quote, Chart TSXV:QIS) gets a target bump from Gabriel Leung of Beacon Securities, who in an update to clients on Tuesday maintained his “Buy” rating with the new target price of $1.50 (previously $1.25).

On Monday, Calgary-based Quorum reported its Q4 and 2018 fiscal year end results, with management saying the quarter was a game-changer for the company, specifically due to the acquisition of DealerMine, completed on October 31, for approximately $9.6 million in cash and $4.4 million in Quorum shares.

“Overall 2018 was a transformative year for Quorum,” CEO Maury Marks said in a press release. “Not only did we further our vision to build a single, integrated, end-to-end business process solution through a build, resell and acquire strategy but we also significantly increased our automotive dealership customer base.”

For the quarter, Quorum reported revenue and EBITDA of $5.9 million and $778,000, respectively, while Leung had forecasted $5.4 million and $458,000, respectively. The analyst noted that recurring SaaS/support revenues were $4.3 million, which was up 58 per cent year-over-year, while the company also generated approximately $874,000 from DealerMine BCE (business development centre), which is also recurring in nature.

Leung says he expects QIS’s top line to increase quarter-over-quarter for Q1, while also noting that the company ended 2018 with $1.7 million in cash against debt of $8.4 million.

“Overall, we believe this was a very promising start to the DealerMine integration with the Oasis acquisition and AutoCanada contract expected to further accelerate growth in 2019,” says Leung.

“We believe this an exciting time for Quorum as it pushes forward with its plan to accelerate market share gains in the North American auto dealership industry based its larger scale and product portfolio. We view the stock as representing a compelling buying opportunity given its large recurring revenue base, growing and profitable operations, and valuation of only 2x recurring SaaS/support revenues,” he says.

The analyst is calling for fiscal 2019 revenue and EBITDA of $27.6 million and $3.5 million, respectively, and fiscal 2020 revenue and EBITDA of $31.7 million and $5.6 million, respectively. His $1.50 target represented a return of 121 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: qis
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 hour ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

17 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

24 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

1 day ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

1 day ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago